Anders Fink-Jensen

18PUBLICATIONS
60CO-AUTHORS
Panel data analysisBehavioural epidemiologyPsychopharmacologyPharmacogenomicsClinimetrics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jan 27, 2026
Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.

Mathias E Jensen, Mette K Klausen, Marianne L Bergmann

|Mar 24, 2025
Blood phosphatidylethanol measurements indicate GLP-1 receptor stimulation causes delayed decreases in alcohol consumption.

Mathias E Jensen, Mette K Klausen, Marianne L Bergmann

|Feb 01, 2025
Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.

Mette Kruse Klausen, Gitte Moos Knudsen, Tina Vilsbøll

|Apr 17, 2024
Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study.

Marie Reeberg Sass, Anne Mette Brandt Christensen, Margit Lykke Christensen

|Feb 05, 2022
Use of chlorprothixene and the risk of diabetes and major adverse cardiovascular events: A nationwide cohort study.

Mikkel Højlund, Christina Blanner Wagner, Rikke Wesselhoeft

Pageof 3